EDSA
Edesa Biotech Inc
3.90$
+1.3%
vs. previous close
Closing price · As of: Oct 5, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | -100.0% | – | |
| – | -2.0% | +0.8% | +13.3% | -14.0% | -2.5% | -43.1% | +5.2% | +0.3% | -1.6% | +1.6% | -0.9% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -26.1% | +67.0% | -23.7% | -88.4% | +881.8% | -52.5% | +93.9% | +30.5% | -8.2% | +146.0% | +43.0% | – | |
| – | -18.6% | -9.4% | -0.9% | -13.0% | -2.4% | +31.4% | -16.4% | +29.0% | -2.3% | +25.7% | +2.1% | – | |
| – | -22.0% | +22.5% | -13.0% | -50.3% | +97.7% | -13.7% | +16.2% | +28.4% | -5.3% | +84.4% | +29.2% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -100.0% | – | -99.5% | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.